Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | RAB9A | P51151 | 4/20 | 0.57 |
| ▸ | NPC1 | O15118 | 4/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 6/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.51 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.51 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.51 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.51 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10541266 | 0.95 | L3MBTL1 (0.56) | L3MBTL1GAAMAPTRAB9ANPC1 | |
| SCHEMBL18766371 | 0.85 | NPC1 (0.56) | L3MBTL1MAPTRAB9ANPC1POLB | |
| SCHEMBL826744 | 0.85 | NPC1 (0.56) | L3MBTL1GAAMAPTRAB9ANPC1 | |
| SCHEMBL10262915 | 0.84 | L3MBTL1 (0.60) | L3MBTL1GAAMAPTRAB9ANPC1 | |
| SCHEMBL10261920 | 0.84 | L3MBTL1 (0.60) | L3MBTL1GAAMAPTRAB9ANPC1 | |
| SCHEMBL10267917 | 0.84 | L3MBTL1 (0.65) | L3MBTL1GAAMAPTRAB9APOLB | |
| SCHEMBL11853573 | 0.83 | L3MBTL1 (0.47) | L3MBTL1GAAMAPTRAB9ANPC1 | |
| SCHEMBL11853579 | 0.83 | L3MBTL1 (0.47) | L3MBTL1GAAMAPTRAB9ANPC1 | |
| SCHEMBL24890713 | 0.83 | NPC1 (0.55) | L3MBTL1MAPTRAB9ANPC1POLB | |
| SCHEMBL1489146 | 0.83 | ALDH1A1 (0.67) | L3MBTL1MAPTRAB9ANPC1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-1029337-A | — | — | None | — | — | JP | disclosed |
| CN-120536025-A | Epoxy coating based on amino-terminated polyarylether oligomer and preparation method thereof | 无锡中油瑞德防腐科技有限公司 | 2025-08-26 | — | — | CN | disclosed |
| EP-2655308-B1 | PROCESS FOR THE MANUFACTURE OF DIBENZOYLMETHANE DERIVATIVES | DSM IP ASSETS BV (NL) | 2018-03-07 | — | — | EP | disclosed |
| US-20170259099-A1 | SILICON-CONTAINING ORGANIC ACID DERIVATIVES AS ENVIRONMENTALLY FRIENDLY AFFF EXTINGUISHING AGENTS | UNIVERSITÄT ZU KÖLN (DE) | 2017-09-14 | — | — | US | disclosed |
| US-9561993-B2 | Process for the manufacture of dibenzoylmethane derivatives | DSM IP ASSETS B.V. (NL) | 2017-02-07 | — | — | US | disclosed |
| US-20140017183-A1 | PROCESS FOR THE MANUFACTURE OF DIBENZOYLMETHANE DERIVATIVES | DSM IP ASSETS B.V. (NL) | 2014-01-16 | — | — | US | disclosed |
| EP-2655308-A1 | PROCESS FOR THE MANUFACTURE OF DIBENZOYLMETHANE DERIVATIVES | DSM IP Assets B.V. (NL) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012084770-A1 | PROCESS FOR THE MANUFACTURE OF DIBENZOYLMETHANE DERIVATIVES | DSM IP ASSETS B.V. (NL) | 2012-06-28 | — | — | WO | disclosed |
| US-8153634-B2 | Carbinol derivatives having cyclic linker | KOWA COMPANY, LTD. (JP) | 2012-04-10 | — | — | US | disclosed |
| EP-2281817-A1 | SUBSTITUTED CARBINOL COMPOUND HAVING CYCLIC LINKER | Kowa Company, Ltd. (JP) | 2011-02-09 | — | — | EP | disclosed |
| US-5021512-A | Curable | LOCTITE (IRELAND) LTD. (IE) | 1991-06-04 | — | — | US | disclosed |
| JP-S6429337-A | CHALCONE DERIVATIVE COMPOUND | NIPPON OILS & FATS CO LTD | 1989-01-31 | — | — | JP | disclosed |
| EP-0162572-B1 | SILOXANE POLYPHOTOINITIATORS OF THE SUBSTITUTED ACETOPHENONE TYPE | LOCTITE CORPORATION (US) | 1989-01-25 | — | — | EP | disclosed |
| US-4732956-A | Styryloxy resins and compositions thereof | LOCTITE (IRELAND) LTD. (IE) | 1988-03-22 | — | — | US | disclosed |
| EP-0229033-A2 | Thiol/ene compositions | LOCTITE (IRELAND) Ltd. (IE) | 1987-07-15 | — | — | EP | disclosed |
| EP-0220831-A2 | Styryloxy resins and polymerization process | LOCTITE (IRELAND) Ltd. (IE) | 1987-05-06 | — | — | EP | disclosed |
| EP-0213893-A2 | Photopolymerisable compositions containing substituted pyrylium salts as photoinitiators; and novel pyrylium salts for use therein | Loctite (Ireland) Limited (IE) | 1987-03-11 | — | — | EP | disclosed |
| EP-0165769-A2 | Polyfunctional styryloxy compounds and method of forming a cross-linked polymer | LOCTITE (IRELAND) Ltd. (IE) | 1985-12-27 | — | — | EP | disclosed |
| US-4543397-A | PERMANENT COLORATION IN CURED PRODUCTS | LOCTITE (IRELAND) LTD. (IE) | 1985-09-24 | — | — | US | disclosed |
| US-4534838-A | Siloxane polyphotoinitiators of the substituted acetophenone type | LOCTITE CORPORATION (US) | 1985-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140017183-A1 | PROCESS FOR THE MANUFACTURE OF DIBENZOYLMETHANE DERIVATIVES | DDT, DHPS, BCDIN3D | L3MBTL1 2015/4885GAA 2239/4885MAPT 1616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.